ARCHIVES

Zaltrap Economics 101: The Pricing And Repricing of an Expensive Drug

This article is from The Cancer Letter archive.

Vol. 38 No. 43 | November 16, 2012

Download PDF Visit The Full Archive

Related Articles

Lynch Named Director, Yale Cancer Center

February 27, 2009

Reviewers Duck Problem Of Naming Four More Comprehensive Centers, Leave It Up To Rauscher To Pick From List Of 11

March 29, 1974

Cancer researchers support “responsible” human stem cell research.

July 22, 2005

NCI To Stop All Support For WHT After March 31

February 5, 1988

In Breif: Baltimore Developer Donates $10 Million To Univ. of Maryland Medical System

July 19, 1996

IOM Panel: NCI Clinical Trials Groups At “Breaking Point,” More Funds Needed.

April 16, 2010